African Potato (Hypoxis) for Anti-Inflammatory

Research suggests that African Potato (Hypoxis hemerocallidea) possesses meaningful anti-inflammatory properties, with evidence pointing to several plausible biological mechanisms. The available evidence includes a 2020 systematic review of existing preclinical literature, two cell and animal studies examining specific compounds and pathways, a rodent model testing the whole extract against acute inflammation and pain, and a mouse study examining gut inflammation, all of which point in a supportive direction. Studies indicate that key bioactive compounds, particularly rooperol derived from hypoxoside, may inhibit COX-1 and COX-2 enzymes, suppress NF-κB inflammatory signaling, and reduce nitric oxide production in macrophage cells, while whole-extract preparations have demonstrated reductions in acute paw inflammation and intestinal inflammation in animal models. However, the evidence base is limited almost entirely to preclinical work in cells and animals, with no published human clinical trials, and the systematic review explicitly notes significant research gaps, meaning these findings cannot yet be directly applied to human health outcomes.